UC-CARE

For hospitals, the Navigo 4D Fusion Navigation System is not just important for providing access to a gold standard of care — it's a...

The MRI fusion-guided biopsy of the future takes biopsies from collection, to analysis, to treatment planning, and provides numerous...

For many practices, the Navigo 4D Fusion Navigation System is not just a clinical innovation—it's a financial growth strategy. With low...

MRI-guided fusion biopsies have transformed prostate cancer detection, offering superior accuracy compared to traditional non-targeted...

A New Era in Prostate Cancer Diagnosis The ultrasound (US)-guided prostate biopsy – also called a “systematic” biopsy – was the...

Approximately 1 million prostate cancer biopsies are performed each year in the U.S., but a recent study found that standard US-guided...

Historically, ultrasound (US)-guided biopsies were the standard of care for diagnosing prostate cancer. However, these “blind” biopsies...

Prostate cancer is the leading cancer affecting men, comprising nearly 15% of all new cancer cases each year. 1 However, despite the...

Historically, ultrasound (US)-guided biopsies defined the standard of care for prostate cancer diagnostics. Recent and emerging evidence,...